Patents Assigned to Quercegne Pharmaceuticals LLC
  • COMPOSITION FOR TREATING MENTAL HEALTH DISORDERS
    Publication number: 20120225833
    Abstract: A composition of three compounds each selected from a selective re-uptake inhibitor of serotonin, a monoamine oxidase inhibitor, and a phosphodiesterase inhibitor, such that all three compounds are different and are naturally occurring.
    Type: Application
    Filed: March 1, 2012
    Publication date: September 6, 2012
    Applicant: Quercegne Pharmaceuticals LLC
    Inventor: Thomas Christian Lines